Beurs gesloten -
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
0,4257 USD | -2,25% | -9,62% | -25,97% |
Omzet 2024 * | - | Omzet 2025 * | - | Marktkapitalisatie | 8,2 mln. 7,7 mln. |
---|---|---|---|---|---|
Nettowinst (verlies) 2024 * | -4 mln. -3,76 mln. | Nettowinst (verlies) 2025 * | -13 mln. -12,21 mln. | EV/omzet 2024 * | - |
Nettoliquiditeiten 2024 * | - 0 | Nettoliquiditeiten 2025 * | - 0 | EV/omzet 2025 * | - |
K/w-verhouding 2024 * |
-2,5
x | K/w-verhouding 2025 * |
-1,42
x | Werknemers | 4 |
Dividendrendement 2024 * |
-
| Dividendrendement 2025 * |
-
| Vrij verhandelbaar | 90,29% |
Recentste transcriptie over Virios Therapeutics, Inc.
1 dag | -2,25% | ||
1 week | -9,62% | ||
Lopende maand | -11,15% | ||
1 maand | -6,93% | ||
3 maanden | -12,12% | ||
6 maanden | -32,02% | ||
Lopend jaar | -25,97% |
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Gregory Duncan
CEO | Chief Executive Officer | 59 | 01-01-18 |
Angela Walsh
DFI | Director of Finance/CFO | 58 | 01-04-20 |
Ralph Grosswald
COO | Chief Operating Officer | 55 | 01-04-20 |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
John Thomas
BRD | Director/Board Member | 70 | 21-12-20 |
Richard Whitley
BRD | Director/Board Member | 78 | 21-12-20 |
Gregory Duncan
CEO | Chief Executive Officer | 59 | 01-01-18 |
Datum | Koers | Variatie | Volume |
---|---|---|---|
22-04-24 | 0,4257 | -2,25% | 72 087 |
19-04-24 | 0,4355 | -3,20% | 63 468 |
18-04-24 | 0,4499 | -0,22% | 62 794 |
17-04-24 | 0,4509 | -0,24% | 87 126 |
16-04-24 | 0,452 | -4,03% | 167 856 |
uitgestelde koers Nasdaq, 22 april 2024 om 22:00 uur
Meer koersenHerzieningen van WPA
Vaira. 1 jan. | Kapi. | |
---|---|---|
-25,97% | 8,2 mln. | |
+2,49% | 96,73 mld. | |
-0,41% | 21,31 mld. | |
-16,61% | 21,21 mld. | |
-4,92% | 18,79 mld. | |
-42,14% | 16,37 mld. | |
-27,40% | 13,68 mld. | |
+1,44% | 13,44 mld. | |
+21,29% | 10,98 mld. | |
-21,79% | 8,56 mld. |